Further Use of Color Coding in Drug Evaluations
- 3 September 1959
- journal article
- research article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 261 (10), 478-482
- https://doi.org/10.1056/nejm195909032611002
Abstract
TN an earlier report1 dealing with orally administered bronchodilator preparations, it was shown that information equivalent to that available by the conventional double-bind technic could be gained by the use of medications coded by color and dispensed in a single bottle. Coding by color appeared to have the advantage of simplicity and ease of administration. To validate this technic and to check its ability to supply reliable data, further inquiry was desirable. The design of such a study would use the same group of drugs coded by two different sets of colors, evaluated by the same patient. The repetitious nature . . .Keywords
This publication has 4 references indexed in Scilit:
- Clinical experience with parabromdylamine maleate (Dimetane), a new antihistaminicJournal of Allergy, 1958
- The use of color-coded tablets in the clinical appraisal of two established bronchodilator preparations and N-[β-(10-phenothiazinyl) propyl] trimethyl-ammonium benzene chlorideJournal of Allergy, 1958
- An appraisal of oral and aerosolized methylphenidate hydrochloride (Ritalin) in obstructive pulmonary diseaseJournal of Allergy, 1958
- A comparative study of Sc-4959 (1-n.-propyl-3-ethyl-5-chloro-6-aminotetrahydropyrimidinedione) and Hyadrine in bronchial asthmaJournal of Allergy, 1956